RelB/p52 NF-κB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IκB-α expression and promote carcinogenesis of the mammary gland

Molecular and Cellular Biology

Volumn 25, Issue 22, 2005, Pages 10136-10147

  Demicco, Elizabeth G ^a   Kavanagh, Kathryn T ^a   Romieu Mourez, Raphaëlle ^a   Wang, Xiaobo ^a   Shin, Sangmin R ^a   Landesman Bollag, Esther ^a   Seldin, David C ^a   Sonenshein, Gail E ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; AGAR; CYCLIN D1; GLUTATHIONE TRANSFERASE; I KAPPA B ALPHA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYC PROTEIN; PROTEIN IKKALPHA; PROTEIN P52; TRANSCRIPTION FACTOR RELB; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST DEVELOPMENT; BREAST EPITHELIUM; CANCER GROWTH; CELL TRANSFORMATION; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GEL MOBILITY SHIFT ASSAY; LONG TERMINAL REPEAT; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; ONCOGENE C MYC; PREGNANCY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; AGAR; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL NUCLEUS; CYCLIN D1; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; I-KAPPA B KINASE; I-KAPPA B PROTEINS; IMMUNOBLOTTING; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, TRANSGENIC; NF-KAPPA B; NF-KAPPA B P52 SUBUNIT; PHENOTYPE; PREGNANCY; PREGNANCY, ANIMAL; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYC; RNA; TIME FACTORS; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB; TRANSFECTION; TRANSGENES;

ANIMALIA; MOUSE MAMMARY TUMOR VIRUS; MUS MUSCULUS;

EID: 27644494143     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.25.22.10136-10147.2005     Document Type: Article

References (64)

1. Arsura, M., M. Wu, and G. E. Sonenshein. 1996. TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells; transcriptional activation of I kappa B alpha. Immunity 5:31-40.
2. Baeuerle, P. A., M. Lenardo, J. W. Pierce, and D. Baltimore. 1988. Phorbol ester-induced activation of the NF-kappa B transcription factor involves dissociation of an apparently cytoplasmic NF-kappa B/inhibitor complex. Cold Spring Harbor Symp. Quant. Biol. 53:789-798.
3. Bonizzi, G., M. Bebien, D. C. Otero, K. E. Johnson-Vroom, Y. Cao, D. Vu, A. G. Jegga, B. J. Aronow, G. Ghosh, R. C. Rickert, and M. Karin. 2004. Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:p52 dimers. EMBO J. 23:4202-4210.
4. Brantley, D. M., C. L. Chen, R. S. Muraoka, P. B. Bushdid, J. L. Bradberry, F. Kittrell, D. Medina, L. M. Matrisian, L. D. Kerr, and F. E. Yull. 2001. Nuclear factor-κB (NF-κB) regulates proliferation and branching in mouse mammary epithelium. Mol. Biol. Cell 12:1445-1455.
5. Brantley, D. M., F. E. Yull, R. S. Muraoka, D. J. Hicks, C. M. Cook, and L. D. Kerr. 2000. Dynamic expression and activity of NF-κB during post-natal mammary gland morphogenesis. Mech. Dev. 97:149-155.
6. Bren, G. D., N. J. Solan, H. Miyoshi, K. N. Pennington, L. J. Pobst, and C. V. Paya. 2001. Transcription of the RelB gene is regulated by NF-κB. Oncogene 20:7722-7733.
7. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. 1995. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267:1485-1488.
8. Calaf, G., and J. Russo. 1993. Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis 14:483-492.
9. Cao, Y., G. Bonizzi, T. N. Seagroves, F. R. Greten, R. Johnson, E. V. Schmidt, and M. Karin. 2001. IKKα provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. Cell 107:763-775.
10. Cao, Y., and M. Karin. 2003. NF-κB in mammary gland development and breast cancer. J. Mammary Gland Biol. Neoplasia 8:215-223.
11. Chen, C., L. C. Edelstein, and C. Gelinas. 2000. The Rel/NF-κB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol. Cell. Biol. 20:2687-2695.
12. Chen, Z. J., L. Parent, and T. Maniatis. 1996. Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell 84:853-862.
13. Clarkson, R. W., J. L. Heeley, R. Chapman, F. Aillet, R. T. Hay, A. Wyllie, and C. J. Watson. 2000. NF-κB inhibits apoptosis in murine mammary epithelia. J. Biol. Chem. 275:12737-12742.
14. Cogswell, P. C., D. C. Guttridge, W. K. Funkhouser, and A. S. Baldwin, Jr. 2000. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3. Oncogene 19:1123-1131.
15. Coope, H. J., P. G. Atkinson, B. Huhse, M. Belich, J. Janzen, M. J. Holman, G. G. Klaus, L. H. Johnston, and S. C. Ley. 2002. CD40 regulates the processing of NF-κB2 p100 to p52. EMBO J. 21:5375-5385.
16. 15a. Currier, N., S. E. Solomon, E. G. Demicco, D. L. F. Chang, M. Farago, H. Ying, I. Dominguez, G. E. Sonenshein, R. D. Cardiff, Z. X. Xiao, D. H. Sherr, and D. C. Seldin. Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors. Toxicol. Pathol., in press.
17. Cusack, J. C., Jr., R. Liu, M. Houston, K. Abendroth, P. J. Elliott, J. Adams, and A. S. Baldwin, Jr. 2001. Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-κB inhibition. Cancer Res. 61:3535-3540.
18. Darnay, B. G., V. Haridas, J. Ni, P. A. Moore, and B. B. Aggarwal. 1998. Characterization of the intracellular domain of receptor activator of NF-κB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-κB and c-Jun N-terminal kinase. J. Biol. Chem. 273:20551-20555.
19. Dobrzanski, P., R. P. Ryseck, and R. Bravo. 1994. Differential interactions of Rel-NF-kappa B complexes with I kappa B alpha determine pools of constitutive and inducible NF-kappa B activity. EMBO J. 13:4608-4616.
20. Dong, X., T. Craig, N. Xing, L. A. Bachman, C. V. Paya, F. Weih, D. J. McKean, R. Kumar, and M. D. Griffin. 2003. Direct transcriptional regulation of RelB by 1α,25-dihydroxyvitamin D3 and its analogs: physiologic and therapeutic implications for dendritic cell function. J. Biol. Chem. 278:49378-49385.
21. Duyao, M. P., A. J. Buckler, and G. E. Sonenshein. 1990. Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter. Proc. Natl. Acad. Sci. USA 87:4727-4731.
22. Duyao, M. P., D. J. Kessler, D. B. Spicer, C. Bartholomew, J. L. Cleveland, M. Siekevitz, and G. E. Sonenshein. 1992. Transactivation of the c-myc promoter by human T cell leukemia virus type 1 tax is mediated by NF kappa B. J. Biol. Chem. 267:16288-16291.
23. Fantl, V., G. Stamp, A. Andrews, I. Rosewell, and C. Dickson. 1995. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev. 9:2364-2372.
24. Fata, J. E., Y. Y. Kong, J. Li, T. Sasaki, J. Irie-Sasaki, R. A. Moorehead, R. Elliott, S. Scully, E. B. Voura, D. L. Lacey, W. J. Boyle, R. Khokha, and J. M. Penninger. 2000. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 103:41-50.
25. Franzoso, G., L. Carlson, L. Poljack, E. W. Shores, S. Epstein, A. Leonardi, A. Grinberg, T. Tran, T. Scharton-Kersten, M. Anver, P. Love, K. Brown, and U. Siebenlist. 1998. Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J. Exp. Med. 187:147-159.
26. Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-κB puzzle. Cell 109(Suppl.):S81-S96.
27. Guttridge, D. C., C. Albanese, J. Y. Reuther, R. G. Pestell, and A. S. Baldwin, Jr. 1999. NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19:5785-5799.
28. Jiang, H. Y., C. Petrovas, and G. E. Sonenshein. 2002. RelB-p50 NF-kappa B complexes are selectively induced by cytomegalovirus immediate-early protein 1: differential regulation of Bcl-x(L) promoter activity by NF-kappa B family members. J. Virol. 76:5737-5747.
29. Kim, D. W., L. Gazourian, S. A. Quadri, R. Romieu-Mourez, D. H. Sherr, and G. E. Sonenshein. 2000. The RelA NF-κB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells. Oncogene 19:5498-5506.
30. Kim, D. W., M. A. Sovak, G. Zanieski, G. Nonet, R. Romieu-Mourez, A. W. Lau, L. J. Hafer, P. Yaswen, M. Stampfer, A. E. Rogers, J. Russo, and G. E. Sonenshein. 2000. Activation of NF-κB/Rel occurs early during neoplastic transformation of mammary cells. Carcinogenesis 21:871-879.
31. La Rosa, F. A., J. W. Pierce, and G. E. Sonenshein. 1994. Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors. Mol. Cell. Biol. 14:1039-1044.
32. Li, N., and M. Karin. 1998. Ionizing radiation and short wavelength UV activate NF-κB through two distinct mechanisms. Proc. Natl. Acad. Sci. USA 95:13012-13017.
33. Lin, X., Y. Mu, E. T. Cunningham, Jr., K. B. Marcu, R. Geleziunas, and W. C. Greene. 1998. Molecular determinants of NF-κB-inducing kinase action. Mol. Cell. Biol. 18:5899-5907.
34. Mercurio, F., H. Zhu, B. W. Murray, A. Shevchenko, B. L. Bennett, J. Li, D. B. Young, M. Barbosa, M. Mann, A. Manning, and A. Rao. 1997. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 278:860-866.
35. Muller, J. R., and U. Siebenlist. 2003. Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways. J. Biol. Chem. 278:12006-12012.
36. Nakshatri, H., P. Bhat-Nakshatri, D. A. Martin, R. J. Goulet, Jr., and G. W. Sledge, Jr. 1997. Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth. Mol. Cell. Biol. 17:3629-3639.
37. Nishimura, T., R. Koike, and M. Miyasaka. 2000. Mammary glands of Aly mice: developmental changes and lactation-related expression of specific proteins, alpha-casein, GLyCAM-1 and MAdCAM-1. Am. J. Reprod. Immunol. 43:351-358.
38. Novack, D. V., L. Yin, A. Hagen-Stapleton, R. D. Schreiber, D. V. Goeddel, F. P. Ross, and S. L. Teitelbaum. 2003. The iκB function of NF-κB2 p100 controls stimulated osteoclastogenesis. J. Exp. Med. 198:771-781.
39. Ozes, O. N., L. D. Mayo, J. A. Gustin, S. R. Pfeffer, L. M. Pfeffer, and D. B. Donner. 1999. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401:82-85.
40. Pianetti, S., M. Arsura, R. Romieu-Mourez, R. J. Coffey, and G. E. Sonenshein. 2001. Her-2/neu overexpression induces NF-κB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IκB-α that can be inhibited by the tumor suppressor PTEN. Oncogene 20:1287-1299.
41. Rayet, B., and C. Gelinas. 1999. Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18:6938-6947.
42. Romieu-Mourez, R., D. W. Kim, S. M. Shin, E. G. Demicco, E. Landesman-Bollag, D. C. Seldin, R. D. Cardiff, and G. E. Sonenshein. 2003. Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors. Mol. Cell. Biol. 23:5738-5754.
43. Romieu-Mourez, R., E. Landesman-Bollag, D. C. Seldin, A. M. Traish, F. Mercurio, and G. E. Sonenshein. 2001. Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-κB in breast cancer. Cancer Res. 61:3810-3818.
44. Schjerven, H., T. N. Tran, P. Brandtzaeg, and F. E. Johansen. 2004. De novo synthesized RelB mediates TNF-induced up-regulation of the human polymeric 1g receptor. J. Immunol. 173:1849-1857.
45. Senftleben, U., Y. Cao, G. Xiao, F. R. Greten, G. Krahn, G. Bonizzi, Y. Chen, Y. Hu, A. Fong, S. C. Sun, and M. Karin. 2001. Activation by IKKα of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293:1495-1499.
46. Sicinski, P., J. L. Donaher, S. B. Parker, T. Li, A. Fazeli, H. Gardner, S. Z. Haslam, R. T. Bronson, S. J. Elledge, and R. A. Weinberg. 1995. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82:621-630.
47. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-kappa B. Annu. Rev. Cell Biol. 10:405-455.
48. Sinn, E., W. Muller, P. Pattengale, I. Tepler, R. Wallace, and P. Leder. 1987. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell 49:465-475.
49. Sonenshein, G. E. 1997. Rel/NF-kappa B transcription factors and the control of apoptosis. Semin. Cancer Biol. 8:113-119.
50. Song, D. H., D. J. Sussman, and D. C. Seldin. 2000. Endogenous protein kinase CK2 participates in Wnt signaling in mammary epithelial cells. J. Biol. Chem. 275:23790-23797.
51. Sovak, M. A., M. Arsura, G. Zanieski, K. T. Kavanagh, and G. E. Sonenshein. 1999. The inhibitory effects of transforming growth factor beta1 on breast cancer cell proliferation are mediated through regulation of aberrant nuclear factor-κB/Rel expression. Cell Growth Differ. 10:537-544.
52. Sovak, M. A., R. E. Bellas, D. W. Kim, G. J. Zanieski, A. E. Rogers, A. M. Traish, and G. E. Sonenshein. 1997. Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer. J. Clin. Investig. 100:2952-2960.
53. Strange, R., F. Li, S. Saurer, A. Burkhardt, and R. R. Friis. 1992. Apoptotic cell death and tissue remodelling during mouse mammary gland involution. Development 115:49-58.
54. Varela, L. M., N. C. Stangle-Castor, S. F. Shoemaker, W. K. Shea-Eaton, and M. M. Ip. 2001. TNFα induces NFκB/p50 in association with the growth and morphogenesis of normal and transformed rat mammary epithelial cells. J. Cell. Physiol. 188:120-131.
55. Verma, I. M., J. K. Stevenson, E. M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev. 9:2723-2735.
56. Voboril, R., S. N. Hochwald, J. Li, A. Brank, J. Weberova, F. Wessels, L. L. Moldawer, E. R. Camp, and S. L. MacKay. 2004. Inhibition of NF-kappa B augments sensitivity to 5-fluorouracil/folinic acid in colon cancer. J. Surg. Res. 120:178-188.
57. Wang, X., and G. E. Sonenshein. 2005. Induction of the RelB NF-κB subunit by the cytomegalovirus IE1 protein is mediated via Jun kinase and c-Jun/Fra-2 AP-1 complexes. J. Virol. 79:95-105.
58. Weih, F., D. Carrasco, S. K. Durham, D. S. Barton, C. A. Rizzo, R. P. Ryseck, S. A. Lira, and R. Bravo. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family. Cell 80:331-340.
59. 1 transition. Mol. Cell. Biol 21:8428-8436.
60. Whiteside, S. T., and A. Israel. 1997. I kappa B proteins: structure, function and regulation. Semin. Cancer Biol. 8:75-82.
61. Wu, M., H. Lee, R. E. Bellas, S. L. Schauer, M. Arsura, D. Katz, M. J. FitzGerald, T. L. Rothstein, D. H. Sherr, and G. E. Sonenshein. 1996. Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J. 15:4682-4690.
62. Xiao, G., E. W. Harhaj, and S. C. Sun. 2001. NF-κB-inducing kinase regulates the processing of NF-κB2 p100. Mol. Cell 7:401-409.
63. Yilmaz, Z. B., D. S. Weih, V. Sivakumar, and F. Weih. 2003. RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF. EMBO J. 22:121-130.
64. Zinser, G. M., and J. Welsh. 2004. Accelerated mammary gland development during pregnancy and delayed postlactational involution in vitamin D3 receptor null mice. Mol. Endocrinol. 18:2208-2223.